DocMorris AG (ZRSEF)
USD 21.6
(-40.36%)
USD 21.6
(-40.36%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 330.81 Million CHF | -37.42% |
| 2022 | 528.63 Million CHF | 0.66% |
| 2021 | 525.15 Million CHF | -0.24% |
| 2020 | 526.43 Million CHF | 47.99% |
| 2019 | 355.72 Million CHF | 203.45% |
| 2018 | 117.22 Million CHF | 2730.84% |
| 2017 | 4.14 Million CHF | -92.99% |
| 2016 | 59.08 Million CHF | -5.92% |
| 2015 | 62.79 Million CHF | 7.79% |
| 2014 | 58.26 Million CHF | -0.6% |
| 2013 | 58.6 Million CHF | -25.16% |
| 2012 | 78.31 Million CHF | 321.93% |
| 2011 | 18.56 Million CHF | -15.87% |
| 2010 | 22.06 Million CHF | 12.72% |
| 2009 | 19.57 Million CHF | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 374.94 Million CHF | 13.34% |
| 2024 Q2 | 374.94 Million CHF | 7.4% |
| 2023 Q2 | 404.59 Million CHF | 6.37% |
| 2023 FY | 330.81 Million CHF | -37.42% |
| 2023 Q4 | 330.81 Million CHF | 1.19% |
| 2023 Q3 | 326.93 Million CHF | -19.19% |
| 2023 Q1 | 380.35 Million CHF | -28.05% |
| 2022 Q4 | 528.63 Million CHF | 1.01% |
| 2022 FY | 528.63 Million CHF | 0.66% |
| 2022 Q2 | 523.08 Million CHF | 0.93% |
| 2022 Q3 | 523.35 Million CHF | 0.05% |
| 2022 Q1 | 518.27 Million CHF | -1.31% |
| 2021 Q1 | 521.24 Million CHF | -0.99% |
| 2021 FY | 525.15 Million CHF | -0.24% |
| 2021 Q4 | 525.15 Million CHF | 1.0% |
| 2021 Q3 | 519.97 Million CHF | -1.37% |
| 2021 Q2 | 527.18 Million CHF | 1.14% |
| 2020 FY | 526.43 Million CHF | 47.99% |
| 2020 Q1 | 517.13 Million CHF | 45.37% |
| 2020 Q4 | 526.43 Million CHF | 1.19% |
| 2020 Q2 | 523.68 Million CHF | 1.27% |
| 2020 Q3 | 520.22 Million CHF | -0.66% |
| 2019 Q3 | 356.06 Million CHF | 102.06% |
| 2019 Q4 | 355.72 Million CHF | -0.1% |
| 2019 FY | 355.72 Million CHF | 203.45% |
| 2019 Q1 | 114.22 Million CHF | -2.56% |
| 2019 Q2 | 176.21 Million CHF | 54.28% |
| 2018 Q1 | - CHF | -100.0% |
| 2018 FY | 117.22 Million CHF | 2730.84% |
| 2018 Q4 | 117.22 Million CHF | 0.72% |
| 2018 Q3 | 116.39 Million CHF | 980.79% |
| 2018 Q2 | 10.76 Million CHF | 0.0% |
| 2017 Q1 | - CHF | -100.0% |
| 2017 FY | 4.14 Million CHF | -92.99% |
| 2017 Q4 | 4.14 Million CHF | 25.33% |
| 2017 Q3 | 3.3 Million CHF | -93.88% |
| 2017 Q2 | 54.01 Million CHF | 0.0% |
| 2016 Q1 | - CHF | -100.0% |
| 2016 FY | 59.08 Million CHF | -5.92% |
| 2016 Q4 | 59.08 Million CHF | 0.0% |
| 2016 Q3 | 59.08 Million CHF | 0.0% |
| 2016 Q2 | - CHF | 0.0% |
| 2015 Q3 | 62.79 Million CHF | 0.0% |
| 2015 Q2 | - CHF | 0.0% |
| 2015 FY | 62.79 Million CHF | 7.79% |
| 2015 Q4 | 62.79 Million CHF | 0.0% |
| 2015 Q1 | - CHF | -100.0% |
| 2014 FY | 58.26 Million CHF | -0.6% |
| 2014 Q4 | 58.26 Million CHF | 0.0% |
| 2014 Q3 | 58.26 Million CHF | 0.0% |
| 2014 Q2 | - CHF | 0.0% |
| 2014 Q1 | - CHF | -100.0% |
| 2013 Q2 | - CHF | 0.0% |
| 2013 Q3 | 58.6 Million CHF | 0.0% |
| 2013 Q4 | 58.6 Million CHF | 0.0% |
| 2013 FY | 58.6 Million CHF | -25.16% |
| 2013 Q1 | - CHF | 0.0% |
| 2012 FY | 78.31 Million CHF | 321.93% |
| 2011 FY | 18.56 Million CHF | -15.87% |
| 2010 FY | 22.06 Million CHF | 12.72% |
| 2009 FY | 19.57 Million CHF | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | -79463.383% |
| Allstar Health Brands, Inc. | 2.21 Million USD | -14867.068% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 16.87 Million USD | -1860.267% |
| Café Serendipity Holdings, Inc. | 412.56 Thousand USD | -80084.746% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 272.02 Thousand USD | -121510.643% |
| HealthWarehouse.com, Inc. | 2.73 Million USD | -11973.906% |
| LIGAND PHARMACEUTICAL INC | 6.16 Million USD | -5266.018% |
| MedGen, Inc. | 24.47 USD | -1351920619.248% |
| Omni Health, Inc. | 1.84 Million USD | -17866.909% |
| Oxford Investments Holdings Inc. | 207.06 Thousand USD | -159663.842% |
| Pineapple, Inc. | 8.1 Million USD | -3979.35% |
| ScripsAmerica, Inc. | 1.2 Million USD | -27403.581% |